Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02649351 2014-02-28
WO 2007/120461 PCT/US2007/008082
COMPOSITIONS AND METHODS FOR CONTROLLING
A HONEY BEE PARASITIC MITE
BACKGROUND OF THE INVENTION
Honey bees, Apis mellifera, are required for the effective pollination of
crops and are
therefore critical to world agriculture. Honey bees also produce economically
important
products, including honey and bees wax. Honey bees are susceptible to a number
of parasites
and pathogens, including the ectoparasitic mite, Varroa destructor. Varroa
mites parasitize
pupae and adult bees and reproduce in the pupal brood cells. The mites use
their mouths to
puncture the exoskeleton and feed on the bee's hemolymph. These wound Sites in
the
exoskeleton harbor bacterial infections, such as Melissococcus pluton, which
causes
European foulbrood. In addition, to their parasitic effects, Varroa mites are
suspected to act
asVectors for a number of honey bee pathogens, including deformed wing virus
(DWV),
Kashmir bee virus (KBV), acute bee paralysis virus (ABPV) and black queen cell
virus
(BQCV), and may weaken the immune systems of their hosts, leaving them
vulnerable to
infections. If left untreated Varroa infestations typically result in colony-
level mortality.
Maintaining a supply of strong honey bee colonies available for pollination is
essential for the
sustained production of farm crops worth more than $14 billion to U.S.
agriculture. During
the winter of 2004-2005, an estimated 40% of the honey bee colonies in the
U.S. were
weakened or collapsed due to Varroa infestation. Current methods of treating
Varroa
infestations are proving to be ineffective as the mites develop resistance to
existing miticides.
In addition, the use of such miticides may introduce injurious chemicals into
honey that is
intended for human consumption. New compositions and methods for treating or
preventing
Varroa mite infestations are urgently required. Desirably, such compositions
would include
only natural ingredients that pose no risk to human health.
=
SUMMARY OF THE INVENTION
As described below, the present invention features methods and compositions
for
controlling a honey bee parasitic mite or for the treatment or prevention Of a
parasitic mite
infestation in a honey bee hive.
1
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
In general, the invention provides a method of controlling a honey bee
parasitic mite
(e.g., Varroa mite, tracheal mite). The method involves contacting the
parasitic mite with an
effective amount of a composition comprising a hop derivative (e.g., alpha
acid, beta acid, or
combination thereof), thereby controlling a honey bee parasitic mite. In one
embodiment, the
contacting of the mite occurs while the mite is in contact with a honey bee
(e.g., honey bee
egg, larva, or pupa).
In a related aspect, the invention provides a method of treating or preventing
a
parasitic mite infestation of a honey bee hive. The method involves contacting
the hive with
an effective amount of a composition comprising a hop derivative, thereby
treating or
preventing a parasitic mite infestation in a honey bee hive.
In another aspect, the method herein further include those wherein the hive or
mite is
identified as in need of the treatment or prevention protocols delineated
herein.
In another aspect, the invention provides a composition for treating or
preventing a
mite infestation, the composition comprising an effective amount of a hop
derivative in a
suitable form for delivery to a mite. Suitable forms include, for example, any
one or more of
liquid, a powder, an oil, an emulsion, a paste, a capsule, a vapor, or any
other form capable
of delivering a hop derivative to a Varroa mite in contact with a honey bee or
honey bee .hive.
If desired, the composition further comprises a carrier.
In yet another aspect, the invention features a composition for treating or
preventing a
mite infestation, the composition comprising an effective amount of a hop
derivative in a
suitable form for delivery to a mite. In one embodiment, the hop derivative is
an alpha acid,
beta acid, or combination of an alpha and a beta acid. In another embodiment,
the hop
derivative is a metal alkali salt or earth alkaline metal salt of hop acid. In
other embodiments,
the composition comprises at least 2.5%, 5%, 7.5%, 15% alpha acids, beta
acids, or a
combination of alpha and beta acids. In another embodiment, the form is
selected from the
group consisting of a liquid, a powder, an oil, an emulsion, a capsule, and a
vapor. In yet
another embodiment, the composition further comprises a carrier (e.g., any one
or more of
maltodextrin, cluster dextrin, corn starch, corn syrup solids, glucose,
cyclodextrin, arabic
gum, calaginan, inuline, rosin, partially hydrogenated soybean oil, cellulose,
hydroxymethyl
cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and hypomellose).
In yet other
embodiments, the composition is a powder having particles of a size selected
from the group
consisting of 1 pm, 5 pm, 10 pm, 25 pm, 50 pm, 75 pm, 100 pm, 150 pm, 200 pm,
500 pm, 1
mm, 2 mm, or 5 mm, such as a powder prepared by spray drying.
2
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
In yet another embodiment, the invention provides a miticide composition
comprising
an effective amount of a hop acid alkali metal salt or hop acid alkaline earth
metal salt and a
carrier in a suitable form for delivery to a mite. In one embodiment, the hop
acid alkali metal
salt is a sodium, potassium, or lithium salt. In another embodiment, the hop
acid alkaline
earth metal salt is calcium or magnesium. In yet another embodiment, the
carrier is selected
from the group consisting of maltodextrin, cluster dextrin, corn starch, corn
syrup solids,
glucose, cyclodextrin, arabic gum, calaginan, inuline, rosin, partially
hydrogenated soybean
oil, cellulose, hydroxymethy cellulose, hydroxyethyl cellulose, hydroxypropyl
cellulose, and
hypomellose. In still other embodiments, the composition is spray dried to
form particles of a
size selected from the group consisting of! gm, 5 gm, 10 gm, 25 gm, 50 gm, 75
gm, 100 gm,
150 gm, 200 gm, 500 gm, 1 mm, 2 mm, and 5 mm in size. In still other
embodiments, the
hop acid to carrier ratio is selected from the group consisting of 1:2, 1:5,
1:10, 1:20, 1:50, and
1:100. In other embodiments, the hop acid maintains miticidal activity for at
least about six
months, nine months, twelve months, eighteen months, twenty-four months, or
thirty-six
months. In still other embodiments, the hop acid maintains stability for at
least about six
months, nine months, twelve months, eighteen months, twenty-four months, or
thirty-six
months.
In yet another aspect, the invention provides a controlled release composition
for
treating or preventing a parasitic mite infestation, the composition
comprising an effective
amount of a hop derivative in a suitable form for delivery to a honey bee
parasitic mite.
In yet another aspect, the invention provides a miticide delivery device, the
device
comprising a composition of any previous aspect. In one embodiment, the device
is selected
from the group consisting of a strip (e.g., membranes, paper, plastic, or
polymer strip),
controlled release strip, tablet, reservoir, polymer disc, evaporation device,
fiber, tube,
polymeric block, membrane, pellet, tray, and microcapillary. If desired, any
of these devices
=
can be formulated in a biodegradable form.
In yet another aspect, the invention provides a hive comprising a composition
of any =
previous aspect.
In yet another aspect, the invention provides a honey bee 'product produced in
a hive
of any previous aspect. Honey bee products include, but are not limited to,
honey, honey
comb, and bees wax.
In yet another aspect, the invention provides a kit for the treatment or
prevention of an
parasitic mite infestation, the kit comprising an effective amount of a hop
derivative in a form
=
3
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
suitable for delivery to a site of infestation (e.g., a bee hive or a bee). In
one embodiment, the
kit features directions for use in a method of the invention.
In yet another aspect, the invention provides a method of identifying a hop
derivative
that disrupts a biological function of a honey bee parasitic mite. The method
involves
contacting the parasitic mite with a test composition comprising a hop
derivative; and
assaying a parasitic mite biological function. In one embodiment, the test
composition
disrupts a parasitic mite biological function (e.g., kills or incapacitates
the parasitic mite or
reduces parasitic mite reproduction). In another embodiment, the method
further includes the
steps of contacting a honey bee with the test composition; and assaying a
honey bee
biological function. In yet another embodiment, the method. identifies a test
compound that
does or does not disrupt a honey bee biological function. In another
embodiment, the method
identifies a test compound that kills a honey bee.
In a related aspect, the invention provides a method of identifying a hop
derivative
that does not disrupt a biological function of a honey bee. The method
involves contacting
the honey bee with a test composition comprising a hop derivative; and
assaying a honey bee
biological function. In one embodiment, the method identifies a test compound
that does or
does not disrupt a honey bee biological function. In another embodiment, the
test compound
kills a honey bee.
In various embodiments of any previous aspect, a hop derivative is an alpha
acid or a
beta acid. In other embodiments of a previous aspect, a composition of the
invention
contains an alpha acid, a beta acid, or a combination thereof, wherein the
amount of alpha or
beta acid in the composition ranges between 1% and 100%, where the bottom
limit of the
range is any integer between 1 and 99% and the upper limit of the range is any
integer
between 2% and 100%. Exemplary amounts of an alpha, a beta, or a combination
thereof
include at least 1%, 2.5%, 5%, 7.5%, 10%, 12%, 15%, 20%, 25%, 35%, 40%, 50%,
60%,
75%, 85%, 90% or 95% in a composition. In one particular embodiment, the
composition
comprises at least 1%, 2%, 2.5%, 3%, 5%, or 10% beta acid and at least 1%, 2%,
3%, 5%,
6%, 7.5%, 8%, 9%, 10%, 12%, or 15 % alpha acids. In one embodiment of any of
the above
aspects, the contacting disrupts a biological function of a mite. Exemplary
biological
functions include any one or more of respiration, neural activity, locomotion,
reproduction, or
any other physiological activity required for mite survival. In one
embodiment, the
contacting kills the mite.
In still other embodiments of any previous aspect, the hop acid alkali metal
salt is a
sodium, potassium, or lithium salt. In other embodiments of any previous
aspect, the hop
4
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
acid alkaline earth metal salt is calcium or magnesium. In other embodiments
of any
previous aspect, the carrier is selected from the group consisting of
maltodextrin, cluster
dextrin, corn starch, corn syrup solids, glucose, cyclodextrin, arabic gum,
calaginan, inuline,
rosin, partially hydrogenated soybean oil, cellulose, hydroxymethy cellulose,
hydroxyethyl
cellulose, hydroxypropyl cellulose, and hypomellose. In still other
embodiments of any
previous aspect, the composition is spray dried to form particles of a size
selected from the
group consisting of 1 gm, 5 gm, 10 pm, 25 gm, 50 pm, 75 gm, 100 gm, 150 pm,
200 gm, 500
gm, 1 mm, 2 mm, and 5 mm in size. In still other embodiments, the hop acid to
carrier ratio
is selected from the group consisting of 1:2, 1:5, 1:10, 1:20, 1:50, and
1:100. In other
embodiments, the hop acid maintains miticidal activity for at least about six
months, nine
months, twelve months, eighteen months, twenty-four months, or thirty-six
months. In still
other embodiments, the hop acid maintains stability for at least about six
months, nine
months, twelve months, eighteen months, twenty-four months, or thirty-six
months.
In yet other embodiments, the composition of the invention is a controlled
release
composition wherein the hop derivative is released over the course of at least
one week to 12
months. For example, the hop derivative is released over at least 5, 10, 14,
28, 36, 41, or 48
days; or is released over the course of 1, 2, 4, 6, 8, 10 or 12 weeks, or even
for as long as 5, 6,
9, or 12 months.
Other features and advantages of the invention will be apparent from the
detailed
description, and from the claims.
Definitions
By "acarid" is meant an arachnid of the order Acarina, which includes mites
and ticks.
By "alpha acid" is meant an organic acid derived from a hop plant (Humulus
lupulus)
having structural homology to a humulone, adhumulone, cohumulone, or an analog
or
derivative thereof. Humulone, adhumulone, and cohumulone are the three most
abundant
alpha acid analogs. Other exemplary derivatives of an alpha acid include, but
are not limited
to isoalpha acids, rhoisoalpha acids, tetrahydroisoalpha acids, and
hexahydroisoalpha acids.
By "beta acid" is meant an organic acid derived from a hop plant (Humulus
lupulus)
having structural homology to a lupulone, adlupulone, colupulone or an analog
or derivative
thereof. Lupulone, adlupulone, and colupulone are the three most abundant beta
acid
analogs. Other exemplary derivatives of a beta acid include, but are not
limited to,
hulupones, hexahydrobeta acids and hexahydro hulupones.
5
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
By "biological function" is meant any physiological or behavioral activity of
an
organism. Exemplary biological functions include reproduction, respiration,
neural activity,
locomotion. Honey production is a biological function that is specific to a
honey bee.
In this disclosure, "comprises," "comprising," "containing" and "having" and
the like
can have the meaning ascribed to them in U.S. Patent law and can mean"
includes,"
"including," and the like; "consisting essentially of' or "consists
essentially" likewise has the
meaning ascribed in U.S. Patent law and the term is open-ended, allowing for
the presence of
more than that which is recited so long as basic or novel characteristics of
that which is
recited is not changed by the presence of more than that which is recited, but
excludes prior
art embodiments.
By "contacting" is meant touching, associating with, or having proximity to a
composition. For example, a hop derivative may contact a hive either inside or
outside of the
hive structure.
By "controlled release" is meant released over the course of hours, days,
weeks, or
months.
By "controlling a parasitic mite" is meant inhibiting mite survival or
reducing,
slowing, or stabilizing the growth of a mite population.
By "comb" is meant sections of hexagonal bee wax cells that are used to rear
honey
bee progeny ("brood") and store honey and pollen.
By "effective amount of a miticide" is meant an amount effective to disrupt a
mite
biological function.
By "hive" is meant a structure that contains a bee colony. A modern box hive
typically includes a bottom board, cover, and one or more boxes, stacked one
above the other.
Inside, each box contains a series of movable frames of comb or foundation
held in a vertical
position a bee space apart.
By "honey bee" is meant a Hymenopteran insect of the genus Apis. The term
"honey
bee" is not limited to the adult form of the insect, but encompasses all honey
bee
developmental stages, including but not limited to egg, larva, and pupa.
Exemplary honey
bee species include Apis mellifera and Apis cerana.
By "honey bee colony" is meant a community of bees. Honey bee colonies may
occur
in the wild or may be maintained by bee keepers.
By "honey bee parasitic mite" is meant any acarid that parasitizes a honey bee
or
infests a honey bee hive. Exemplary honey bee parasitic mites include Varroa
mites and
6
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
By "hop derivative" is meant any molecule that naturally occurs in hops
(Humulus
lupulus) and chemical derivatives thereof. Hop derivatives (e.g., alpha acids,
beta acids) may
= be purified from hops or may be chemically synthesized.
By "infestation" is meant the colonization of a site or the parasitization of
an
organism by a pest.
By "miticide" is meant an agent that inhibits a biological function of a mite.
By "miticidal activity" is meant any activity that inhibits the growth,
reproduction, or
survival of a mite or other acarid.
By "preventing a mite infestation" is meant reducing the success that a mite
infestation will be established in an Apis colony.
By "treating a mite infestation" is meant reducing, stabilizing, or slowing
the growth
of a mite population in an Apis colony.
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1 is a graph showing Varroa mite and honey bee mortality at four hours
and
twenty-two hours respectively in response to hop product exposure at the
indicated
concentrations.
Figures 2 is a graph showing Varroa mite and honey bee mortality four hours
and at
twenty-four hours respectively in response to-hop product exposure at the
indicated
concentrations.
Figure 3 is a graph showing Varroa mite and honey bee mortality at one hour
and
twenty-four hours respectively in response to hop product exposure at the
indicated
concentrations.
Figures 4 is a graph showing Varroa mite mortality at five hours and adult
honey bee
mortality at twenty-four hours in response to hop product exposure at the
indicated
concentrations. MgBeta denotes magnesium salts of beta acids. RIAA denotes
rhoisoalpha
acids.
Figure 5 is a graph showing Varroa mite and honey bee mortality at twenty-four
hours
in response to hop product exposure at the indicated concentrations.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is directed to methods and compositions to control
acarids and
other related species of the family Varroidae. The invention is based, in
part, on the
7
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
discovery that naturally occurring components of hops are useful for the
prevention or
treatment of a Varroa mite infestation.
Apis
Honey bees are insects that pass through four life stages: the egg, larva,
pupa and
adult. Adult bees belong to one of three castes: queen, worker, or drone. The
queen bee is
the only female in the colony that is capable of reproduction and is
responsible for all egg
production. The worker bees are non-reproductive females who gather honey and
care for
the queen's progeny, or "brood." The drones are male bees that mate with the
queen. The
life cycle, from egg to adult bee, takes twenty-one days for worker bees and
twenty-four days
for drones. The queen bee lays each egg in a single cell of the comb. The egg
generally
hatches into a larva on the fourth day, which continues its development within
the cell. On
the ninth day the cell with the developing larva is capped with wax and the
larva undergoes
pupal metamorphosis. On day twenty-one, a new adult worker bee emerges.
Aca rids
Acarids are small parasitic arachnids that act as parasites on a variety of
plants and
animals, including honey bees. Parasitic mites that prey on honey bees include
Varroa mites
(e.g., Varroa destructor, Varroa jacobsoni) and tracheal mites (e.g., Acarapis
woodi)
Tracheal mites are microscopic mites that inhabit the respiratory tubes of
bees. Varroa mites
are ectoparasites that feed on bee hemolymph, and infest wild and domestic
honey bee
colonies. Varroa mite reproduction begins when the adult female mite enters a
brood cell
shortly before it is capped. Drone brood, which is reared in larger cells than
worker brood, is
preferentially targeted for mite infestation. The female mite feeds on the
larval hemolymph
prior to depositing her eggs. The Varroa eggs eclose under the sealed cell,
and the
developing mites feed on the bee pupa. The first egg laid by the female Varroa
develops into
a male. Subsequent eggs develop into females that mate with their brother. The
mated
female mites along with their mother are released from the capped cell when
the bee emerges.
The female mites typically attach to adult bees between the abdominal segments
or between
body regions, where they feed on the bees' hemolymph. Adult bees serve as
intermediate
hosts and as a means of transport to new sites of infestation.
Desirably, rniticides used in acarid control should address the following four
needs: i)
should disrupt a physiological function required for mite survival; ii) should
cause no adult
8
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
bee mortality; iii) should have no adverse effects on human bee keepers or
honey intended for
human consumption; and iv) should be capable of delivery into the hive.
Mite Control
Products used to control honey bee parasitic mite infestation reduce,
stabilize, or slow
the growth of a mite population in a hive or inhibit the growth, survival,
reproduction, or
other biological function of a honey bee parasitic mite. Preferably, the
miticide kills the mite.
Methods for measuring parasitic mite infestation are known in the art. A
number of
parameters can be indicative of the level of infestation present in a bee
colony: the number of
mites present in a sample of bees from an infested hive can be used as one
measure of the
level of infestation present in the hive; bees reared in a hive having an
active infestation are
on average smaller than bees reared in a hive without infestation; thus, bee
size or weight can
be used as another measure of infestation; the amount of honey produced in an
infected hive
may be less than that produced in a healthy hive; accordingly, honey
production could serve
as yet another measure of the level of infestation; and finally, severe
infestations result in
complete loss of colonies. Thus, loss of colonies can be a measure of the
level of infestation
present in the hive. In one embodiment, a miticide of the invention reduces
the level of
infestation in a hive by at least 10%, 25%, 50%, 75% or even by 100%. In
another
embodiment, a miticide of the invention induces at least 50%, 60%, or 70% mite
lethality.
Preferably, the miticide induces 75%, 80%, 90%, or even 95% or 100% mite
lethality.
Screening methods are used to identify concentrations of hop derivatives that
will be lethal to
a mite (e.g., induce at least 70% mite lethality) while minimizing lethal
effects on adult bees.
Alternatively, a miticide of the invention inhibits mite reproduction.
Preferably, the
miticide reduces mite reproduction by at least 25%, 50%, 75% or 100%. In
another
approach, the miticide disrupts a biological function required for acarid
locomotion; such
treatment allows the mite to be trapped, drowned, isolated, or otherwise
removed from an
area.
Miticide Screening
Commercial products that are currently being used to control mite infestation
can be
lethal to adult bees when administered at high concentrations, can have
adverse effects on
human bee keepers, and may contaminate honey intended for human consumption.
Conventional miticides include Tau-Fluvalinate (a synthetic-pyrethroid
compound used as a
selective contact and stomach poison) and Coumaphos (a systemic organic
phosphate) used
9
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
on animals to control lice, ticks and mites. In contrast to conventional
miticides,
compositions of the invention contain safe natural products derived from hops.
Hops have
been used for centuries to flavor beer; thus, formulations comprising hop
derivatives are
generally safe. Miticidal compositions of the invention will not adversely
affect human bee
keepers or honey intended for human consumption.
Miticides of the invention contain concentrations of hop derivatives that have
few or
no adverse effects on honey bees during any of their life stages, but are
effective in killing or
disrupting the biological functioning of a mite. As reported herein, beta
acids, a hop
derivative, delivered at 4% concentration killed 87% of exposed mites after
four hours while
causing 0% lethality in adult bees. In one approach, mites are exposed to
varying
concentrations of hop derivatives to identify those concentrations that kill
50% to 100% of
the exposed mite. Adult honey bees are then exposed to concentrations of hop
derivatives
having miticidal activity to identify those that have a minimal effect on
honey bee survival.
Preferably, at least 75%, 80%, 85%, 90%, 95%, or 100% of adult bees will
survive following
exposure to a miticidal composition. In a similar approach, the effect of hop
derivatives on
mite and honey bee reproduction is assessed. Screening assays are used to
determine the
concentration of a miticide that reduces the number of eggs laid by the female
mite, reduces
the number of eggs that hatch, or reduces the number of mites that grow to
reproductive
maturity; preferably, the reduction is by at least 25%, 50%, 75%, 85%, 95% or
100%.
Hop Derivatives
A hop derivative is a compound that occurs naturally in a hop plant (Humulus
lupulus)
or is chemically derived (either through natural biosynthetic procesess (e.g.,
living organism
metabolism (e.g., mammal, plant, bacteria)) or by synthetic processes using
human
intervention (e.g., chemical synthesis). Compositions of the invention include
one or more
compounds derived from hops. Of particular interest are the hop acids. Hops
contain two
major organic acid classes, alpha acids and beta acids. Hop acids are the
bitter acid
components of hops that are used in beer making. There are three major analogs
for alpha
acids, humulone, cohumulone, and adhumulone, and three major analogs for beta
acids,
lupulone, colupulone, and adlupulone. The percentages of the analogs present
in the alpha
acids and beta acids are variety-dependent. Thus, hop derivatives and hop
products typically
contain one or a mixture of these analogs. The percentage of analog present is
dependent on
the hop variety used to produce the derivative or product. Alpha acids and
beta acids can be
prepared by purification from natural hops and also by chemical synthesis
according to
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
traditional methods. Exemplary hop derivatives include beta acids,
hexahydrobeta acids,
rhoisoalpha acids, isoalpha acids, tetrahydroisoalpha acids, hexahydroisoalpha
acids,
magnesium salts of rhoisoalpha acids and magnesium salts of beta acids.
Compositions
comprising hop derivatives are also available commercially. John I. Haas, Inc.
products
containing hop derivatives include Betacide, Redihop , Isohop , Tetrahop Gold
, Hexahop
Gold , MgRIAA and MgBeta. The active ingredients in these products are beta
acids,
rhoisoalpha acids (RIAA), isoalpha acids (IAA), tetrahydroisoalpha acids
(THIAA),
hexahydroisoalpha acids (HHIAA), magnesium salts of rhoisoalpha acids (MgRIAA)
and
magnesium salts of beta acids (MgBeta), respectively. For convenience, the
identities of
these products are also listed in Table 1. These products and/or hop
derivatives are typically
diluted to a desired concentration for use in the methods of the invention.
Plant extracts are often used for the purification of compounds from plants
(e.g.,
hops). An extract can be prepared by drying and subsequently cutting or
grinding the dried
material. The term "extract" refers to a concentrated preparation of the
essential constituents
of a plant, such as hops. Typically, an extract is prepared by drying and
powderizing the
plant. Optionally, the plant, the dried plant or the powderized plant may be
boiled in
solution. The extract may be used in liquid form, or it may be mixed with
other liquid or
solid herbal extracts. Alternatively, the extract may be obtained by further
precipitating solid
extracts from the liquid form. The extraction process may then be performed
with the help of
an appropriate choice of solvent, typically ethanol/water mixture, methanol,
butanol, iso-
butanol, acetone, hexane, petroleum ether or other organic solvents by means
of maceration,
percolation, repercolation, counter-current extraction, turbo-extraction, or
by carbon-dioxide
supercritical (temperature/pressure) extraction. The extract may then be
further evaporated
and thus concentrated to yield by means of air drying, spray drying, vacuum
oven drying,
fluid-bed drying or freeze-drying, the extract product.
Crude extracts are tested for miticidal activity as described herein. Further
fractionation of a positive lead extract having miticidal activity is
necessary to isolate
chemical constituents responsible for the observed effect. Thus, the goal of
the extraction,
fractionation, and purification process is the careful characterization and
identification of a
chemical entity within the crude extract that disrupts a mite biological
function. Methods of
fractionation and purification of such heterogeneous extracts are known in the
art. If desired,
compounds shown to be useful as miticides are chemically modified according to
methods
known in the art.
11
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Numerous methods are available for the chemical synthesis of candidate
compounds.
Such compounds can be synthesized from readily available starting materials
using standard
synthetic techniques and methodologies known to those of ordinary skill in the
art. Synthetic
chemistry transformations and protecting group methodologies (protection and
deprotection)
useful in synthesizing the compounds identified by the methods described
herein are known
in the art and include, for example, those such as described in R. Larock,
Comprehensive
Organic Transformations, VCH Publishers (1989); T. W. Greene and P. G. M.
Wuts,
Protective Groups in Organic Synthesis, 2nd ed., John Wiley and Sons (1991);
L. Fieser and
M. Fieser, Fieser and Fieser's Reagents for Organic Synthesis, John Wiley and
Sons (1994);
L. Paquette, ed., Encyclopedia of Reagents for Organic Synthesis, John Wiley
and 'Sons
(1995); and M. Verzele and D. De Keukeleire, Chemistry and Analysis of Hop and
Beer
Bitter Acids, Elsevier: Amsterdam (1991). Chemically synthesized alpha and
beta acids can
be separated from a reaction mixture and further purified by a method such as
column =
chromatography, high pressure liquid chromatography, or recrystallization. As
can be
appreciated by the skilled artisan, further methods of synthesizing the
compounds herein will
be evident to those of ordinary skill in the art. Additionally, the various
synthetic steps may
be performed in an alternate sequence or order to give the desired compounds.
The compounds of this invention may contain one or more asymmetric centers and
thus occur as racemates and racemic mixtures, single enantiomers, individual
diastereomers
and diastereomeric mixtures. All such isomeric forms of these compounds are
expressly
included in the present invention. The compounds of this invention may also be
represented
in multiple tautomeric forms, in such instances, the invention expressly
includes all
tautomeric forms of the compounds described herein. All such isomeric forms of
such
compounds are expressly included in the present invention. All crystal forms
of the
compounds described herein are expressly included in the present invention. As
used herein,
the compounds of this invention, including the compounds of formulae described
herein, are
defined to include derivatives. Derivatives include compounds of the invention
that are
modified by appending appropriate functionalities to enhance desired
properties.
Acceptable salts of the compounds of this invention include those derived from
acceptable inorganic and organic acids and bases. Examples of suitable acid
salts include
acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate,
butyrate, citrate,
camphorate, camphorsulfonate, digluconate, dodecylsulfate, ethanesulfonate,
formate,
fumarate, glucoheptanoate, glycolate, hemisulfate, heptanoate, hexanoate,
hydrochloride,
hydrobromide, hydroiodide, 2-hydroxyethanesulfonate, lactate, maleate,
malonate,
12
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
methan.esulfonate, 2-naphthalenesulfonate, nicotinate, nitrate, palmoate,
pectinate, persulfate,
3-phenylpropionate, phosphate, picrate, pivalate, propionate, salicylate,
succinate, sulfate,
tartrate, thiocyanate, tosylate and undecanoate. Other acids, such as oxalic
acid, may be
employed in the preparation of salts useful as intermediates in obtaining the
compounds of
the invention and their acceptable acid addition salts. Salts derived from
appropriate bases
include alkali metal (e.g., sodium), alkaline earth metal (e.g., magnesium),
ammonium and N-
(a1ky1)4+ salts. This invention also envisions the quatemization of any basic
nitrogen-
containing groups of the compounds disclosed herein. Water or oil-soluble or
dispersible
products may be obtained by such quatemization.
In some embodiments, miticidal compositions of the invention include water
soluble
hop acid alkali metal salts (e.g., sodium, potassium, lithium salts) and water
insoluble hop
acid alkaline earth metal salts (e.g., calcium, magnesium) having increased
stability. These
hop acid alkali metal salt (e.g., sodium, potassium, lithium salts) and water
insoluble hop acid
alkaline earth metal salt (e.g., calcium, magnesium) compositions are
advantageously stable
relative to hop acids produced by conventional methods, which are susceptible
to degradation
due to heat, light, and acid catalysis. Compositions of the invention remain
stable under
conditions that induce the degradation of other conventional hop acids. In
particular, after 6
months to 1 year of storage, the compositions of the invention are expected to
retain at least
about 50%, 60%, 75%, 80%, or preferably at least about 90%, 95% or even 100%
of the hop
acids present at the time of application. Surprisingly, hop B acid crystals
are also resistant to
degradation and exhibit increased stability. Accordingly, hop B acid crystals
are also useful
in the compositions and methods of the invention.
Water soluble hop acid alkali metal salts (e.g., sodium, potassium, lithium
salts) and
water insoluble hop acid alkaline earth metal salts (e.g., calcium, magnesium)
are typically
present in a diluent or carrier at levels ranging from about 0.1% to about
95%. The methods
herein contemplate administration of an effective amount of compound or
compound
composition to achieve the desired or stated miticidal effect. Preferably, the
amount of active
ingredient (e.g., hop acid alkali metal salts, hop acid alkaline earth metal
salts or
combinations thereof) are combined with carrier materials (e.g., maltodextrin,
cluster dextrin,
corn starch, corn syrup solids, glucose, cyclodextrin, arabic gum, calaginan,
inuline, partially
hydrogenated soybean oil, cellulose, hydroxymethyl cellulose, hydroxyethyl
cellulose,
hydroxypropyl cellulose, rosin, hypomellose) to form a powder suitable for
delivery. For
some applications, miticides of the invention are formulated as liquids using
diluents (e.g.,
13
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
sucrose or glucose solutions, water, juices, other aqueous solutions, water
miscible solvents
(ethanol, cremophor, dimethylsulfoxide (DMSO), dimethylformarnide (DMF),
isopropanol
(IPA) or glycerol, and other solvents)) to form a solution or slurry.
A typical miticidal preparation will contain from about 1% to about 95% hop
acid,
where the bottom of the range is any integer between 5 and 94 and the top of
the range is any
integer between 6 and 95, where the hop acids are provided in a carrier (e.g.,
maltodextrin,
cluster dextrin, corn starch, corn syrup solids, glucose, cyclodextrin, arabic
gum, calaginan,
inuline, rosin, partially hydrogenated soybean oil, cellulose, hydroxymethyl
cellulose,
hydroxyethyl cellulose, hydroxypropyl cellulose, hypomellose) that is suitable
for use in
methods of producing a product having miticidal activity. Where non-aqueous
miticidal
compositions are desired, the miticidal of the invention are preferably
formulated with rosin
or partially hydrogenated soybean oil. Such compositions may be used for the
slow release
of the active miticidal composition, for example, in an aqueous slurry. In
still other
embodiments, miticidal compositions of the invention are dispersed in
cellulose powder. In
each of the aforementioned embodiments, the hop acid alkali metal (e.g.,
sodium, potassium,
lithium), alkaline earth metal salts (e.g., calcium, magnesium), or other hop
acid salts are
dispersed or dissolved in water, ethanol, or another diluent together with any
one or more of
maltodextrin, cluster dextrin, corn starch, corn syrup solids, glucose,
cyclodextrin, arabic
gum, calaginan, inuline, rosin, partially hydrogenated soybean oil, cellulose,
hydroxymethyl
cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and hypomellose.
The
composition is then spray dried to facilitate the formation of particles less
than 1 mm in size.
Preferably, the conditions used for spray drying are adjusted such that the
particles are at least
about 1 pm, 5 pm, 10 pm, 25 pm, 50 pm, 75 pm, 100 pm, 150 pm, 200 pm, 500 gm,
1 mm, 2
mm, or 5 mm in size. The ratio of hop acids to carrier ranges between about
1:2 and 1:100.
Preferred ratios include 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20,
1:30, 1:50, 1:75, and
1:100. Alternatively, compositions of the invention include at least about 1%,
10%, 20%, =
30%, 50%, 60%, 75%, 80%, 90%, or 95% hop acid alkali metal (e.g., sodium,
potassium,
lithium) or hop acid alkaline earth metal salts (e.g., calcium, magnesium) in
a diluent or
carrier. Not all of the hop acids need be in the metal form. Anywhere between
5% and 100%
of the hop acids present in the composition are in the metal form at any given
time, and
between 95% and 0% are present as free acids. In various embodiments, a
composition of the
invention contains hop acids where 90% are present in the metal form and 10%
are present in
the acid form; 50% are present in the metal form and 50% in the acid form; and
10% are
present in the metal form and 90% in the acid form.
14
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
In preferred embodiments, the preparation includes between 1 and 95% (e.g., 1,
2, 3,
4, 5, 6, 7, 8, 9, 10, 25%, 75%, 80%, 90%, 95%) hop acids in a carrier or
diluent.
Alternatively, such preparations contain from about 20% to about 80% hop
acids.
Compositions containing alpha or beta acids are manufactured by ordinary
methods. Hop
acids suitable for addition to products can be formulated as ordinary tablets,
capsules, solids,
liquids, emulsions, slurries, fine granules or powders, which are suitable for
administration to
products during their preparation, following preparation but prior to storage,
or at any time
prior to their sale to a vendor or consumer. Lower or higher amounts than
those recited
above may be required. The compositions delineated herein include the
compounds of the
formulae delineated herein, as well as additional miticidal agents if present,
in amounts
effective for inhibiting mite growth or survival. Miticidal compositions of
the invention may
be used in virtually any application where the inhibition of a mite is
desired. For example,
compositions of the invention are used to prevent, reduce, inhibit, slow or
stabilize the
growth, proliferation, or survival of a mite.
Lower or higher doses than those recited herein may be required to effectively
kill
mites without adversely affecting honey bees. Specific dosage and treatment
regimens are
determined empirically as described herein. Compositions of the invention are
also useful for
preventing the establishment of an acarid infestation, for treating an
established acarid
infestation, and for maintaining the health of a hive previously treated for
an acarid
infestation.
Formulations
Hop derivatives can be provided to bees or bee hives in a number of convenient
formulations. In general, strategies for dispersing a therapeutic or
prophylactic agent within
the hive rely on i) providing the agent in a food source (e.g., a liquid or
solid food); ii)
providing the agent in a composition that will induce hygienic behavior
designed to remove
the composition from the colony (a packet designed to be tom apart by the
bees); or iii)
providing the agent in a form that the bees will distribute throughout the
colony (e.g., a
tracking powder provided at an entrance to the hive). Formulations of the
invention are used
to target mites on the body of adult bees, in the brood cell, or in the hive.
Desirably, the
composition of the invention is active in the hive for at least forty-one
days. This provides
for the presence of the miticide for the entirety of the mite life cycle,
which typically is
completed over the course of twenty-one to thirty days. Where activity is
maintained for a
shorter period (e.g., seven, fourteen, twenty-one, or thirty days), repeated
administration of a
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
composition of the invention may be desired or required. Compositions that are
active for
longer periods (e.g., two, three, six, nine, or twelve months) are also
envisioned. Such
compositions may be used for the long-term treatment or prevention of a mite
infestation.
Powdered formulations
Current miticides are introduced into the beehive on plastic non-biodegradable
strips
that are about 1" wide, 9" long and VI" thick. Similar means could be used for
the delivery of
hop derivatives. Other strip compositions include, but are not limited to,
membranes, paper,
plastic, and polymer strips. In one embodiment, a composition comprising a hop
derivative is
provided in a powdered formulation. A substrate material is coated with a
powdered
formulation of hop acids, and the coating is subsequently encased in a layer
of a substance
that is attractive to bees, such as powdered sugar. This strip is placed
inside the beehive
where the adult bees chew into the powdered sugar and expose the powdered hop
acids. The
powdered hop acids get onto the body of the adult bees, thereby contacting
mites present on
the adult bees and causing the mites to die. Alternatively, the hop acids are
consumed by the
bees and enter their hemolymph, where they are subsequently consumed by the
mites,
thereby causing the mites to die.
In another approach, the powdered mixture is delivered to the hive within a
semi-
permeable pouch that resembles a "teabag". To rid the hive of this foreign
object, the bees
rip up the pouch, thereby releasing the powder. The powdered hop acids get
onto the body of
the adult bees and are distributed throughout the hive, thereby killing (or
otherwise
interfering with mite proliferation or survival) mites present on the bees and
inhibiting the
mite infestation.
Encapsulated formulations
In one approach, a hop derivative is provided in an encapsulated formulation
(liquid
or powder). Preferably, a hop derivative in liquid or powder form is
encapsulated in a
coating that breaks down slowly inside the beehive. The coating provides for
the long-term
release of the hop derivative. Preferably, the composition is released over
the course of two
to six weeks (e.g., two, three, four, five, six weeks). Specific materials
suitable for use in
capsule materials include, but are not limited to, porous particulates or
substrates such as
silica, perlite, talc, clay, pyrophyllite, diatomaceous earth, gelatin and
gels, polymers (e.g.,
polyurea, polyurethane, polyamide, polyester, etc.), polymeric particles, or
cellulose. These
include, for example, hollow fibers, hollow tubes or tubing which release a
hop derivative or
other compound specified above through the walls, capillary tubing which
releases the
compound out of an opening in the tubing, polymeric blocks of different
shapes, e.g., strips,
16
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
blocks, tablets, discs, which release the compound out of the polymer matrix,
membrane
systems which hold the compound within an impermeable container and release it
through a
measured permeable membrane, and combinations of the foregoing. Examples of
such
dispensing compositions are polymer laminates, polyvinyl chloride pellets, and
microcapillaries. Encapsulation methods suitable for use in apiculture are
described, for
example, by Rieth et al., Journal of Apiculture Research 25(2):78-84 (1986).
Encapsulation processes are typically classified as chemical or mechanical.
Examples
of chemical processes for encapsulation include, but are not limited to,
complex coacervation,
polymer-polymer incompatibility, interfacial polymerization in liquid media,
in situ
polymerization, in-liquid drying, thermal and ionic gelation in liquid media,
desolvation in
liquid media, starch-based chemistry processes, trapping in cyclodextrins, and
formation of
liposomes. Examples of mechanical processes for encapsulation include, but are
not limited
to, spray drying, spray chilling, fluidized bed, electrostatic deposition,
centrifugal extrusion,
spinning disk or rotational suspension separation, annular-jet encapsulation,
polymerization
at liquid-gas or solid-gas interface, solvent evaporation, pressure extrusion
or spraying into
solvent extraction bath.
Microcapsules are also suitable for the long-term release of miticides.
Microcapsules
are small particles that contain a core material or active ingredient
surrounded by a coating or
shell. The size of the microcapsule typically varies from 1 to 1000 microns
with capsules
smaller than 1 micron classified as nanocapsules and capsules larger than 1000
microns as
macrocapsules. Core payload usually varies from 0.1 to 98 weight percent.
Microcapsules
can have a variety of structures (continuous core/shell, multinuclear, or
monolithic) and have
irregular or geometric shapes.
In another approach, the hop derivative is provided in an oil-based delivery
system.
The oil-hop derivative mix is deposited on a solid substrate and the substrate
containing the
hop derivative is placed into the hive where it subsequently contacts and
kills the mites. Oil
release substrates include vegetable and/or mineral oils. In one embodiment,
the substrate
also contains a surface active agent that renders the composition readily
dispersable in water;
such agents include wetting agents, emulsifying agents, dispersing agents, and
the like.
Miticides of the invention can also be provided as emulsions. Emulsion
formulations
can be found as water in oil (w/o) or oil in water (o/w). Droplet size can
vary from the
nanometer scale (colloidal dispersion) to several hundred microns. A variety
of surfactants
and thickeners are usually incorporated in the formulation to modify the size
of the droplets,
stabilize the emulsion, and modify the release.
17
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Alternatively, miticides of the invention may also be formulated in a solid
tablet and
comprise (and preferably consist essentially of) an oil, a
protein/carbohydrate material
(preferably vegetable based), a sweetener and an active ingredient useful in
the prevention or
treatment of a parasitic infection in a honey bee. Methods for making such
compositions are
known in the art and are described, for example, in U.S. Patent Publication
No.
20060008492. In one embodiment the invention provides a solid tablet and
comprises (and
preferably consist essentially of) an oil, a protein/carbohydrate material
(preferably vegetable
based), a sweetener and an active ingredient (e.g., hops a and/or 13 acid, or
combinations or
derivatives thereof) useful in the prevention or treatment of a mite
infestation. Tablets
typically contain about 4-40% (e.g., 5%, 10%, 20%, 30%, 40%) by weight of an
oil (e.g.,
plant oil, such as corn, sunflower, peanut, olive, grape seed, tung, turnip,
soybean, cotton
seed, walnut, palm, castor, earth almond, hazelnut, avocado, sesame, croton
tiglium, cacao,
linseed, rape-seed, and canola oils and their hydrogenated derivatives;
petroleum derived oils
(e.g., parafins and petroleum jelly), and other water immiscible hydrocarbons
(e.g., parafins).
The tablets further contain from about 5-40% (e.g., 5%, 10%, 20%, 30%, 40%) by
weight of
a vegetable-based protein/carbohydrate material. The material contains both a
carbohydrate
portion (e.g., derived from cereal grains, such as wheat, rye, barley, oat,
corn, rice, millet,
sorghum, birdseed, buckwheat, alfalfa, mielga, corn meal, soybean meal, grain
flour, wheat
middlings, wheat bran, corn gluten meal, algae meal, dried yeast, beans, rice)
and a protein
portion. While the relative fraction of each portion making up the material
may vary, the
material should include at least a portion of carbohydrate and protein.
The tablets also contain between about 10-75% (10, 15, 20, 25, 50, 75%) by
weight of
a sweetner. As used herein, the term "sweetner" generally refers to both
natural and artificial
sweeteners. Preferably, the sweetener is a sugar such as glucose, fructose,
sucrose, galactose,
lactose, and reversed sugar. The sugar is preferably selected from the group
consisting of
granulated sugar (white sugar), brown sugar, confectioner's sugar, impalpable
sugar, icing
sugar, and combinations thereof. Alcohols such as glycerin and complex
carbohydrates, such
as starches may also be used as the "sweetener" ingredient. The sweetener is
used primarily
as an attractant for the insects, however the sweetener also helps to impart a
granular
structure to the tablets, especially when the sweetener is a sugar. As
previously discussed,
this granular structure permits the tablet to crumble over time upon the
exertion of sufficient
forces.
Optionally, various excipients and binders can be used in order to assist with
delivery
of the active ingredient or to provide the appropriate structure to the
tablet. Preferred
18
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
excipients and binders include anhydrous lactose, microcrystalline cellulose,
corn starch,
magnesium estearate, calcium estearate, zinc estearate, sodic
carboxymethylcellulose, ethyl
cellulose, hydroxypropyl methyl cellulose, and mixtures thereof.
Tablets according to the present invention are manufactured by mixing all of
the
ingredients together and then compressing the mixture into a tablet of desired
shape and size
for a particular application. Preferably, the tablet is discoid in shape with
a diameter of
between about 2-5 inches and a thickness of from about 0.5-2 inches. The
pressing may be
accomplished by a manual or automatic pressing device. The pressure exerted on
the mixture
should be sufficient so as to form the tablet into a self-sustaining body.
Methods of delivering an active ingredient to an insect according to the
present
invention comprise the steps of providing a solid tablet containing the active
ingredient as
previously described and placing the tablet in a location where the insect may
come into
direct contact therewith. In treating honeybees that are generally colonized
in a manufactured
bee hive, the tablet is preferably placed inside the hive.
Over the next several weeks after the tablet is placed into the hive, the bees
chew and
crumble the tablet exposing the active ingredient to the other bees. The
crumbs fall through
the brood box away from the honey supers. Preferably, the entire tablet is
disintegrated in
about 30-45 days.
Miticides of the invention can also be delivered in the form of syrups that
are
attractive to bees and induce feeding behavior. The syrups for use in the
invention preferably
comprise sugar and water. Particularly preferred are 50% w/v sucrose
solutions. A liquid
composition is formed by dispersing hops acids in a sugar syrup comprising 50%
sucrose in
water. The composition is used as a feed supplement for the bees and can be
placed at a
suitable location in or near a hive.
Miticides of the invention can also be delivered in packets suitable for
inducing
hygienic behavior in bees. Such packets are prepared by enclosing a fine
powder of hops
acids and sugar in a porous material capable of being torn apart by bees.
Preferably, the
porous material is made of waxed paper or filter paper. Suitable filter papers
include those
comprising abaca fibers, wood pulp and cellulose rayon fibers. If desired, the
paper is coated
with polyethylene mixed with copolymers, polypropylene mixed with copolymers
or 100%
polypropylene.
In other embodiments, rniticides are prepared in a dusting composition or as a
powder. Dusting compositions are typically prepared by grinding sugar to a
fine powder and
mixing it into the powder hops acids. Alternatively, the dusting compositions
are prepared as
19
CA 02649351 2014-02-28
WO 2007/120461
PCT/US2007/008082
described in Example 3 for maltodextrin, where the powder is obtained by spray
drying. The
skilled artisan adjusts the conditions used in the spray drying process to
achieve particles or
granules of a size that facilitates delivery to the bees. Desirably, the
powder comprises fine
particles that coat the bee and all of its body parts (e.g., joints, groove,
bristles). The dusting
composition can be applied directly to the top of the bee frames, to the combs
within the hive,
or to the interior surfaces of the hive, or may be applied directly to a bee
cluster.
Alternatively, the miticides are prepared in a liquid spray composition that
is formed
by dispersing hops acids in any suitable liquid. Preferably, the hops acids
are dispersed in
water. If desired, the spray composition also includes a surfactant that
allows the spray to be
dispersed efficiently without clogging the spraying apparatus. The composition
can be used
to spray the hive interior, or the comb, or can be used to spray bee clusters
directly.
In another approach, miticides of the invention are delivered in the form of a
vapor.
Methods for delivering such vapors to a hive are described, for example, in
U.S. Patent
Publication No. 20020151249.
Miticide Delivery
Devices for delivering pest control agents to bees or to a bee hive are known
in the
art. Such delivery devices include strips, controlled release strips, tablets,
reservoirs, polymer
discs, trays, and evaporation devices. If desired, the delivery device is
provided in a
biodegradable form. In particular, devices suitable for delivering a
composition of the
invention to a parasitic mite, to a honey bee, or to a honey bee hive are
described, for
example, in U.S. Patent Publication Nos. 20070059333; 20070026765;
20060141904;
20060009122; 20060008492; 20050095954; 20050090560; 20050048093; 20040229542;
20040077291; 20030190860; 20030044443; 20030027490; 20020182977; 20020151249;
20020094756; 20010014346 and 20020151249. Dispensing means and suitable
compositions for controlled release are described in U.S. Pat. Nos. 6,843,985;
5,750,129;
4,775,534; 5,849,317; 5,348,511; 6,037,374; 7,137,864; 6,837,770; 6;820,773;
6,702,645;
6,646,014; 6,620,025; 6,595,828; 6,585,557, 6,475,061, 6,468,129; 6,277,371;
6,221,375;
= 6,204,283; 6,096,350; 6,037,374; 6,010,390; 5,312,622; 5,230,894;
5,227,162; 5,135,758;
5,070,091; 5,069,651; 5,023,359; 4,876,265; 4,867,731; 4,837,216; 4,682,380;
and
4,299,816.
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Kits
The invention provides kits for the treatment or prevention of an acarid
infestation. In
one embodiment, the kit includes a composition containing an effective amount
of a hop
derivative in a form suitable for delivery to a site of infestation (e.g., bee
hive). In some
embodiments, the kit comprises a container which contains a miticide; such
containers can be
boxes, ampules, bottles, vials, tubes, bags, pouches, blister-packs, or other
suitable container
forms known in the art. Such containers can be made of plastic, glass,
laminated paper, metal
foil, or other materials suitable for holding miticides.
If desired the miticide of the invention is provided together with
instructions for
administering it to a site of infestation. The instructions will generally
include information
about the use of the composition for the treatment or prevention of an acarid
infestation. In
other embodiments, the instructions include at least one of the following:
description of the
miticide; dosage schedule and administration for treatment or prevention of a
miticide
infestation; precautions; warnings; description of research studies; anclior
references. The
instructions may be printed directly on the container (when present), or as a
label applied to
the container, or as a separate sheet, pamphlet, card, or folder supplied in
or with the
container.
EXAMPLES
Example 1: Hop Beta and Alpha Acids used in Miticide Screening
Beta acids, alpha acids, and a combination of beta and alpha acids were
screened for
efficacy as miticides. Liquid test products containing beta acids were
provided in a Betastab
10A0 formulation (10% beta acids) hereinafter called "Betacide". Liquid test
products
containing alpha acids were provided in a Redihop formulation (30%
rhoisoalpha acids),
Isohop formulation (30% isoalpha acids), Tetrahop Gold formulation (9%
tetrahydroisoalpha acids), Hexahop Gold formulation (5% hexahydroisoalpha
acids and 5%
tetrahydroisoalpha acids). A combination of alpha and beta acids were prepared
by mixing
equal parts Redihop and Betacide. Powdered test products containing beta
acids were
provided by a magnesium salt formulation of beta acids. Powdered test products
containing
alpha acids were provided by magnesium salt formulations of Redihop , Tetrahop
Gold
and Hexahop Gold .
21
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Tests were carried out using the concentrations of beta, alpha, or beta and
alpha acid
combinations indicated in Table 1.
Specifically, in Tests 1-4: 5% beta acids as Betacide test solution, 15%
rhoisoalpha
acids as Redihop test solution, and a 2.5% beta acids/7.5% rhoisoalpha acids
combination
was used.
In Tests 5-8, 4% beta acids as Betacide test solution, 30% rhoisoalpha acids
concentration as Redihop test solution, and a 2% beta acids/15% rhoisoalpha
acids
combination were used. =
In Tests 9-12, 4% beta acids as Betacide test solution, 30% rhoisoalpha acids
concentration as Redihop test solution, and a 2% beta acids/15% rhoisoalpha
acids
combination were used.
In Tests 13-15, 30% isoalpha acids as Isohop , 9% tetrahydroisoalpha acids as
Tetrahop Gold , and a combination of 5% tetrahydroisoalpha acids and 5%
hexahydroisoalpha acids from Hexahop Gold were used.
In Tests 16-19, 4.3% and 8.5% beta acids as a magnesium salt, and 65.5%
rhoisoalpha
acids as a magnesium salt of Redihop were used.
In Tests 20-22, 25.3% tetrahydroisoalpha acids as a magnesium salt of Tetrahop
Gold , and a combination of 12.2% each of tetrahydroisoalpha acids and
hexahydroisoalpha
acids from magnesium salts of Hexahop Gold were used.
Miticide Screening Assays
Tests using liquid hop products were conducted by absorbing one milliliter of
test
solution onto a filter paper in a Petri dish. Tests using the powdered hop
products
(magnesium salts) were conducted by spreading 0.5 gm of test powder evenly
over filter
paper in a Petri dish. Five to ten Varma mites were then placed on the treated
filter paper and
mite survival was determined at one, four or five and twenty-four hours hour
time points.
Similar methods were used to evaluate the effect of the test compounds on
adult honey bee
survival. Adult honey bee survival was scored after twenty-two hours exposure
to test
product. Five to ten adult honey bees were placed in Petri dishes containing
treated filter
paper. Filter paper treated with water (for liquid test solutions) or
cornstarch (for powdered
test solutions) was used as a negative control for tests with the mites and
the adult honey
bees. All trials were replicated four times.
22
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Table 1 outlines the tests and results of testing various hop products for
miticidal
activity.
23
Table I. Hop Derivatives Efficacy Against Varroa Mites of Honey Bees
Test Figure Product Test acid%
%Mortality/EXposure Time
0
Number Number Product Active Ingredient (ai) Conc.
% Alpha Beta Diluent Mites Hours Bees Hours t..)
I I deionized water none
NA NA NA none 7 4 0 22 o
=
-4
2 1 Betacide beta acids 10
NA 5 deionized water 73 4 20 22
t..)
3 1 Redihop rhoisoalpha acids 30
15 NA deionized water 21 4 0 22 o
.6.
o
4 1 Redihop + Betacide as in test 2+ test 3
30 + 10 7.5 2.5 deionized water 43 4 7 22
2 deionized water none
NA NA NA none 7 4 0 24
6 2 Betacide beta acids = 10
NA 4 deionized water 87 4 0 24
7 2 Redihop rhoisoalpha acids 30
30 NA deionized water 68 4 0 24
8 2 Redihop + Betacide as in test 2 + test 3 30 + 10 15
2 deionized water 80 4 0 24
= 0
9 3 deionized water none
NA NA NA none 0 1 0 24 0
I.)
0,
3 Betacide beta acids 10 NA
4 deionized water 20 1 ND 24 .1,.
ko
UJ
N 11 3 Redihop rhoisoalpha acids 30
30 NA deionized water 13 1 ND 24
4=,
H
12 3 Redihop + Betacide as in test 2 + test 3 30 + 10 15
2 deionized water 13 1 ND 24 I.)
0
13 3 Isohop isoalpha acids 30
30 NA deionized water 70 1 33 24 0
0
1
14 3 Tetrahop Gald tetrahydroisoalpha acids 9
9 NA deionized water 81 1 0 24 H
0
I
3 Hexahop Gold hexahydroisoalpha acids plus 5 5 NA deionized water
100 1 7 24 0
0
tetrahydroisoalpha acids 5 5 NA
16 4 corn starch none NA NA NA none
13 5 ND ND
17 4 MgBeta magnesium salt of beta acids 59.5
NA 4.3 corn starch 38 5 ND ND
18 4 MgBeta magnesium salt of beta acids 59.5
NA 8.5 corn starch 67 5 0 24
19 4 MgRIAA magnesium salt of rhoisoalpha acids 65.5
65.5 NA corn starch 7 5 ND ND 1-d
n
1-i
5 corn starch none NA NA NA none
17 24 0 24 cp
t..)
21 5 MgTetrahop Gold mg salt of tetrahydroisoalpha acids 75.8
25.3 NA corn starch 50 24. 0 24 o
=
-4
22 5 MgHexahop Gold mg salt of hexahydroisoalpha acids 36.7
12.2 NA corn starch 50 24 0 24 =
o
Go
plus mg salt of tetrahydroisoalpha acids 36.7
12.2 NA =
Go
t..)
Notes: NA means Not Applicable, ND means No Data
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Results for the tests described in Table 1 are shown in Figures 1-5.
In Tests 1-4 after five hours exposure, 5% beta acids killed 73% of Varroa
mites; 15%
rhoisoalpha acids killed 21% of Varroa mites; and a combination of 2.5% beta
acids/7.5%
rhoisoalpha acids produced 43% mortality of mites. Under control conditions
only 7% mite
mortality was observed. The majority of adult bees survived exposure to these
same
concentrations of alpha and beta acids. Specifically, 100% adult bees survived
exposure to
rhoisoalpha acids; 80% of adult bees survived exposure to 5% beta acids; and
93% of adult
bees survived exposure to the combination of 2.5% beta acids/7.5% alpha acids.
These
results are presented in Table 1 and Figure 1.
In Tests 5-8 following four hours of exposure, 4% beta acids killed 87% of
Varroa
mites; 30% rhoisoalpha acids killed 68% of mites; and the combination of 15%
rhoisoalpha
acids and 2% beta acids killed 80% of mites. 7% mite mortality was observed
under control
conditions. Adult bees exposed to these same product concentrations for 24
hours showed
100% survival. These results are presented in Table 1 and Figure 2.
In Tests 9-15 after one hour of exposure, 4% beta acids killed 20% of Varroa
mites;
30% rhoisoalpha acids killed 13% of mites; the combination of 15% rhoisoalpha
acids and
2% beta acids killed 13% of mites; 9% tetrahydroisoalpha acids killed 81% of
mites; the
combination of 5% tetrahydroisoalpha acids and 5% hexahydroisoalpha acids
killed 100% of
mites. No mite mortality was observed under control conditions. Adult bees
exposed to
these product concentrations for 24 hours showed 67% survival after exposure
to isoalpha
acids; 93% survival after exposure to the combination of 5% tetrahydroisoalpha
acids and 5%
hexahydroisoalpha acids; 100% survival after exposure to 9% tetrahydroisoalpha
acids; and
100% survival after exposure to control conditions. These results are
presented in Table 1
and Figure 3.
In Tests 16-19, after five hours of exposure, 8.5% beta acids in the form of a
magnesium salt killed 67% of Varroa mites; 65.45% rhoisoalpha acids in the
form of a
magnesium salt killed 7% of Varroa mites. 13% of mites died under control
conditions.
100% of bees survived after 24 hours exposure to 8.5% beta acids as a
magnesium salt.
These results are presented in Table 1 and Figure 4.
In Tests 20-22 after 24 hours of exposure, 25.27% tetrahydroisoalpha acids in
the
form of the magnesium salt killed 50% of Varroa mites; and a combination of
12.23%
tetrahydroisoalpha acids and 12.23% hexahydroisoalpha acids both in the form
of magnesium
salt killed 50% of Varroa mites. 17% of mites died under control conditions.
100% of adult
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
=
honey bees survived for 24 hours under the same conditions. These results are
presented in
Table 1 and Figure 5.
Example 2: Miticidal Effect of Hop Acids in Simulated Apiary Assays
In the apiary, a bee brush was used to gently sweep bees into a 1/2 cup
measuring cup.
To prevent them from flying, the side of the bee brush was used as a lid over
the cup. The 1/2
cup of bees was transferred to a 1/2 pint or pint Mason jar with a screened
lid (i.e., a sugar
shake jar). One jar containing a 1/2 cup of bees was used per container of
treatment.
The containers were prepared by inserting a screen at the opening of the
container and
placing a cut piece of sticky board in the lid of the container. The lids were
attached to the
containers and the containers were turned upside down so that from bottom to
top there was a
lid, sticky board, and screen. A #5 rubber cork was placed in one of the two
feeding holes.
One jar of bees was placed briefly into the -20 freezer. The bees remained in
the freezer until
bee movement slowed considerably (3 to 5 minutes). At this point the bees were
ready for
painting using Bee paint ¨ Testors43 or another similar. brand. Bees were
removed from the
freezer and dumped onto a metal tray. A small dot of paint was deposited on
the thorax of
each bee using a small paint brush. The painted bees were placed into the
container by
dropping them through the feeding hole until all of the bees in the jar were
painted.
The desired amount of treatment was prepared and administered by quickly
placing
. 20 the bees in the Mason jar together with a mixture containing 2 grams
of a 1:1 mixture of 52%
magnesium salt of hop beta acids (Mgbeta) and cornstarch or a corn starch
control. The bees
in the jar were then rolled in the powder until they were completely covered
in powder. Bees
were then transferred to a new container where miticidal activity was assayed.
During the
assay, the bees were fed a 1:1 solution of sucrose with hot water and were
maintained in an
incubator at 32.5 C and 60 % humidity. Bee mortality was monitored daily.
Feeders were
replenished by removing / refilling the vials and temporarily replacing the
rubber corks.
The treated bees were shaken in sugar shake to determine how many mites
remained
on the bees after one week. This method involves mixing 1/2 cup of bees with a
few
tablespoons of powdered sugar and shaking the bees vigorously. The loose sugar
and mites
are collected, and the mites are counted. The number of mites present after
the sugar shake is
combined with the number of dead mites that were found on the sticky boards to
determine
the Total Number of mites per container (T1-T4). The mortality percentages
were calculated
by dividing the number of dead mites on the sticky boards by the total number
of mites.
26
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Treatment Group Mite Mortality
= Ti 92.86 % mite mortality
T2 83.33%
T3 90.9%
T4 (control) 42.86 % mite mortality
The total number of mites in each treatment group, which included
approximately 80 bees,
ranged from 7 to 14.
Example 3: Sodium and Magnesium Salts of Hop Acids Kill Mites
Tests using the powdered hop products (magnesium salts) were conducted by
spreading test powder evenly over filter paper in a Petri dish. The MgBeta
test powder
contained a 1:1 mixture of 0.25 g of magnesium salt of beta acids (52%
magnesium beta salts
of hop acids) and corn starch; thus, 26% magnesium salt of beta acids was used
in the assay.
The NaBeta test powder contained a 1:1 mixture of 0.25 g of sodium salt of
beta acids (6.4%
sodium salt of beta acids); thus, 3.2% magnesium salt of beta acids was used.
Varroa mites
were placed on the treated filter paper and mite survival was determined at
one, two, three,
four or five hours following exposure. Results are shown in Table 2.
=
27
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
=
Table 2: MITE BIOASSAY ¨ 0.25g Treatment
=
Date = # Hours Exposure Treatment '% Mortality
3/28/07 1 MgBeta 4.8
NaBeta 15.1
Cornstarch 0
Control 0
2 MgBeta 9.5
NaBeta 45.2
Cornstarch 0
Control 11.1
3 MgBeta 14.3 =
NaBeta 45.2
Cornstarch 0
Control 11.1
4 MgBeta 28.6
NaBeta 75.4
Cornstarch 0
Control 16.7
5 MgBeta 57.1
NaBeta 89.7
Cornstarch 0
Control 39.2
Example 4: Preparation of water-soluble beta acid sodium salts
Step 1: Commercially available hop CO2 extract (55%: Alpha acids, 30% Beta
acids,
10% uncharacterized residue) (10kg) is placed into Tank 1. CO2 extracts are
produced by
natural carbon dioxide extraction of hops. Carbon dioxide is a natural solvent
that eliminates
residual solvents that typically present in hop extracts produced using hexane
or ethylene
chloride solvents. Food grade KOH (100g) is dissolved in deionized water
(20L). The KOH
solution is added into the Tank 1 and the mixture is stirred at 55-65 C for 1
hour and then
agitation is stopped to form two layers.
Step 2: The lower aqueous layer (15L) is transferred into Tank 2. The crude
beta acid
potassium salts are cooled down to room temperature for two hours and then
Celite
(diatomaceous earth) is added (0.5% wt/wt mix) for 20-30 minutes. The
resulting mixture is
filtered through a Buchner type filtration apparatus under vacuum.
28
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Step 3: The filtrate (10L) is transferred to Tank 3 and heated to 70 C with
agitation
and then acidified with 30% of aqueous H2SO4 until the mixture reaches pH 2-3.
The
agitation is stopped, and the mixture is allowed to form two layers. The upper
layer (5L),
=
which is retained, contains about 70% beta acids.
Step 4: Aqueous NaOH solution (about 9L) is added to the upper layer (3L) and
the
pH is adjusted to pH 10-10.5 at 65 C with agitation then active charcoal
(Norit A 200
mesh) (2% wt/wt mix) is added to the solution, which is gently stirred for
thirty minutes. The
mixture is incubated overnight and then filtered. The filtrate is diluted with
deionized water
to achieve 10% beta acid sodium salts in an aqueous composition.
Alternatively, the
mixtures is passed over a columm containing 60 mesh active charcoal.
Example 5: Preparation of powder of hop beta acid sodium salts
Hop beta acids are prepared as described in Example 4 with the following
modification. In step 4 of Example 4, aqueous maltodextrin solution was
prepared at pH 10
by mixing an aqueous beta acid sodium salts solution with maltodextrin, such
that the hop
acids to maltodextrin ration is 5 : 1 to 10:1 ratio after the filtration. The
solution is dried by =
spray drying to obtain a pale yellow powder containing 5-10% beta acid sodium
salts.
Example 6: Preparation of hop beta acid sodium salts in 67% Et0H solution
Beta acids are prepared as described in Example 4 with the following
modification.
In step 4 of Example 4, 500 ml of the aqueous solution, which contains about
30% beta acid
sodium salts is mixed with 1000m1 of 100% Et0H with stirring to form 67% pale
yellow
ethanol solution containing 10% beta acid sodium salts.
Example 7: Preparation of beta acid sodium salts in 90% Et0H solution
500 ml of an aqueous solution containing about 30% beta acid sodium salts is
neutralized with 0.1 N H2SO4. The beta acid-rich fraction is precipitated out
at pH 7-9. The
solid is separated and washed with water three times. The solid (200 g) is
dissolved into
1700 ml of 100% Et0H under stirring. 100m1 of aqueous NaOH solution (16g of
NaOH and
84m1 of water) is added to the Et0H solution under stirring to form a pale
yellow clear 90%
ethanol solution that contains 10% beta acid sodium salt.
29
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Example 8: Stability study of hop acids.
The following samples containing hop acids were incubated under aerobic
conditions at
75 C for 0-6 days. Liquid samples were dissolved in a volume of 0.1m1
Samples
1. Beta acids rich hop extract (10%) in water (pH= 5.0)
2. Powder of 10% Beta acids and 90% Maltodextrin
3. Powder of 5% Beta acid Na salts and 95% Maltodextrin
4. Powder of 10% Beta acid Na salts and 90% Maltodextrin
5. 10% beta acid Na salts in water (pH = 10)
6. Hop extract with 10% hop beta acid Mg salts
Following this incubation, the presence of hop acids was assayed. After
incubation of 20 mg
of each sample at 75 C under aerobic conditions, the sample was dissolved into
lml of 70%
aqueous Et0H. The solution was diluted 50 times with methanol and then 20uL of
the
diluted sample was injected into a high pressure liquid chromatography (HPLC)
for analysis.
= The HPLC conditions used were:
Temperature: 35 C
Eluent A : 10 mM Triethylammoniurn acetate / water
Fluent B : 10 mM Triethylammoniurn acetate / acetonitrile
Gradient: Fluent B = from 30% to 90% in 20 minutes then keep B=90% for 5
minutes
Detection : 370 nm for beta acids, 254 nm for other degradation peaks
Determination: Area under the curve of three peaks (15-17min) at 370 nm
Authentic sample: International Calibration Extract 2 from American Society of
Brewing Chemists
HPLC Type : Agilent HP1100 series with diode array detector.
Samples referred to in Table 3 are described abvoe as Samples 1-6. As shown in
Table 3, alkali salts of beta acids (sample 3, 4, and 5) were more stable than
the neutral form
of beta acids in neutral or acidic conditions (1, 2 and 6). The results of
these studes are
summarized in Table 3.
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
Table 3: Stability study of hop beta acids under force conditions
Sample Beta acids remained (%)
Period (Day)
1 3 6
1 52 20 0
2 40 15 0
3 100 100 98
4 100 100 100
100 90 90
6 60 25 0
This method provides for the rapid assessment of the chemical stability of hop
acid salts
relative to the degradation observed in hop acids. The degradation observed
after six days at
5 75 C is equivalent to the degradation that would be expected if the hop
acids and salts were
stored for 6 months at room temperature.
Example 9. Preparation of rhoisoalpha acid salts
An inorganic salt of rhoisoalpha acids is produced using any standard method
known
in the art. In one embodiment, a rhoisoalpha acid is produced according to the
following
method.
An empty drum was placed on a scale and tared. To the drum was added 80 kg of
a
mixture of rhoisoalpha acids (30%) in deionized water (75L) at room
temperature. The
mixture was subjected to gentle agitation to form an aqueous slurry. MgSO4
(45kg) was
added to the slurry at one time and the agitation was continued for 5-10
minutes until the
MgSO4 was homogeneously distributed. After 10 minutes, a small sample was
removed to
determine whether the reaction had reached completion. This was determined
using an
HPLC to assay the presence of rhoisoalpha acids magnesium salt. When the
reaction was
complete, the mixture was removed and deionized water was added to adjust the
concentration of rhoisoalpha acids magnesium salt to 15-17% having 83-85%
water content.
The mixture was then dried using standard methods. When the drying was
completed, the
flaky products were packed in aluminum coated polyethelene bags, heat sealed
and stored at
room temperature prior to analysis.
Example 10: Preparation of rhoisoalpha acids calcium salts
To prepare the calcium salt of rhoisoalpha acid, 300 grams of an aqueous 30%
rhoisoalpha acid solution having a pH of 11 was mixed with 37 grams of CaC12-
2H20,
31
CA 02649351 2008-10-08
WO 2007/120461
PCT/US2007/008082
which had been mixed previously with 200mL deionized water. This slurry was
mixed until
homogeneous. The slurry was then poured directly onto a drying tray and dried.
Example 11: Preparation of rhoisoalpha acids lithium salts
To prepare the lithium salt of rhoisoalpha acid, 300 grams of an aqueous 30%
rhoisoalpha acid solution having a pH of 9 was mixed with 21 grams of Li0H-
H20, which
had been mixed previously with 300mL deionized water. This slurry was mixed
until
homogeneous. The slurry was then filtered through a Buchner funnel to remove
excess water
and placed onto a drying tray and dried.
Example 12: Preparation of rhoisoalpha acids calcium salts
To prepare the calcium salt of rhoisoalpha acid, 300 grams of an aqueous 30%
rhoisoalpha acid solution having a pH of 11 was mixed with 37 grams of CaC12-
2H20,
which had been mixed previously with 200mL deionized water. This slurry was
mixed until
homogeneous. The slurry was then poured directly onto a drying tray and dried.
Example 13: Preparation of rhoisoalpha acids potassium salts
To prepare the potassium salt of rhoisoalpha acid, 300 grams of an aqueous 30%
rhoisoalpha acid solution having a pH of 10 was mixed with 35 grams of K2CO3
which had
been mixed previously with 300mL deionized water. This slurry was mixed until
homogeneous. The slurry was then poured directly onto a drying tray and dried.
Example 14: Preparation of tetrahydroisoalpha acid calcium salts
To prepare the calcium salt of tetrahydroisoalpha acid, 1000 grams of an
aqueous 9%
tetrahydroisoalpha acid solution having a pH of 10.5 was mixed with 42 grams
of CaC12-
2H20, which had been mixed previously with 100mL deionized water. This slurry
was
mixed until homogeneous. The slurry was then filtered through a Buchner funnel
to remove
excess water and placed onto a drying tray and dried.
Virtually any hop acid alkali salt (e.g., sodium, potassium, lithium), hop
acid alkaline
earth metal salt (e.g., magnesium, calcium salts), or other hop acid salts may
be used in the
process set forth above. As set forth in the above examples, the invention
provides processes
for producing Water soluble alkali salts or water insoluble alkaline earth
metal salts of alpha
acids or beta acids. Virtually any isoalpha acid, rhoisoalpha acid,
tetrahydroisoalpha acid,
32
CA 02649351 2014-02-28
=
WO 2007/120461
PCT/US2007/008082
hexahydroisoalpha acid, beta acid, hexahydrobeta acid, tetrahydrobeta acid,
lupulone,
colupulone, adlupulone, or derivatives or combinations thereof may be used in
the processes
of the invention. In one embodiment, the concentration of hop acids present in
the aqueous
solution ranges between 5% and 50%, inclusive. In other embodiments, the
concentration
ranges between 5-45% (e.g., 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, and 45%),
=
inclusive. In yet other embodiments, the lower end of the range is any number
between 9 and
49%; and the upper end of the range is any number between 10 and 50%. The hop
acids of
step 4 may be dried to obtain salts any standard method or combination of
methods, including
but not limited to, spray drying, vaccum drying, drum drying, pan drying,
window drying and
freeze drying. Preferably, spray drying is used.
Compounds of the invention are prepared in a manner essentially as described
above
and in the general schemes. The recitation of a listing of chemical groups in
any definition of
a variable herein includes definitions of that variable as any single group or
combination of
listed groups. The recitation of an embodiment for a variable herein includes
that
embodiment as any single embodiment or in combination with any other
embodiments or
portions thereof. Another embodiment is a compound of any of the formulae
herein made by
a process delineated herein, including the processes exemplified in the
schemes and examples
herein. Another aspect of the invention is a compound of any of the formulae
herein for use.
in as a miticide as delineated herein.
Other Embodiments
From the foregoing description, it will be apparent that variations and
modifications
may be made to the invention described herein to adopt it to various usages
and conditions.
Such embodiments are also within the scope of the following claims.
The recitation of a listing of elements in any definition of a variable herein
includes
definitions of that variable as any single element or combination (or sub
combination) of
listed elements. The recitation of an embodiment herein includes that
embodiment as any
single embodiment or in combination with any other embodiments or portions
thereof.
33
